506 related articles for article (PubMed ID: 34367181)
1. Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.
Minaga K; Watanabe T; Hara A; Yoshikawa T; Kamata K; Kudo M
Front Immunol; 2021; 12():713779. PubMed ID: 34367181
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease.
Watanabe T; Minaga K; Kamata K; Kudo M; Strober W
Trends Immunol; 2018 Nov; 39(11):874-889. PubMed ID: 30401468
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.
Hara A; Watanabe T; Minaga K; Yoshikawa T; Kamata K; Kudo M
World J Gastroenterol; 2021 May; 27(19):2257-2269. PubMed ID: 34040320
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Dysbiosis and Autoimmune Pancreatitis.
Yoshikawa T; Watanabe T; Kamata K; Hara A; Minaga K; Kudo M
Front Immunol; 2021; 12():621532. PubMed ID: 33833754
[TBL] [Abstract][Full Text] [Related]
5. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.
Minaga K; Watanabe T; Hara A; Kamata K; Omoto S; Nakai A; Otsuka Y; Sekai I; Yoshikawa T; Yamao K; Takenaka M; Chiba Y; Kudo M
Sci Rep; 2020 Sep; 10(1):14879. PubMed ID: 32938972
[TBL] [Abstract][Full Text] [Related]
6. Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic Cells.
Watanabe T; Yamashita K; Arai Y; Minaga K; Kamata K; Nagai T; Komeda Y; Takenaka M; Hagiwara S; Ida H; Sakurai T; Nishida N; Strober W; Kudo M
J Immunol; 2017 May; 198(10):3886-3896. PubMed ID: 28373582
[TBL] [Abstract][Full Text] [Related]
7. Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis.
Minaga K; Watanabe T; Arai Y; Shiokawa M; Hara A; Yoshikawa T; Kamata K; Yamashita K; Kudo M
J Gastroenterol; 2020 May; 55(5):565-576. PubMed ID: 31960143
[TBL] [Abstract][Full Text] [Related]
8. High-fat diet aggravates experimental autoimmune pancreatitis through the activation of type I interferon signaling pathways.
Sekai I; Minaga K; Hara A; Otsuka Y; Kurimoto M; Omaru N; Okai N; Masuta Y; Takada R; Yoshikawa T; Kamata K; Kudo M; Watanabe T
Biochem Biophys Res Commun; 2022 Dec; 637():189-195. PubMed ID: 36403482
[TBL] [Abstract][Full Text] [Related]
9. Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells.
Kamata K; Watanabe T; Minaga K; Hara A; Yoshikawa T; Okamoto A; Yamao K; Takenaka M; Park AM; Kudo M
Int Immunol; 2019 Nov; 31(12):795-809. PubMed ID: 31287532
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of Staphylococcus sciuri into the pancreas.
Yoshikawa T; Minaga K; Hara A; Sekai I; Kurimoto M; Masuta Y; Otsuka Y; Takada R; Kamata K; Park AM; Takamura S; Kudo M; Watanabe T
Int Immunol; 2022 Dec; 34(12):621-634. PubMed ID: 36044992
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid Dendritic Cell Activation and IFN-α Production Are Prominent Features of Murine Autoimmune Pancreatitis and Human IgG4-Related Autoimmune Pancreatitis.
Arai Y; Yamashita K; Kuriyama K; Shiokawa M; Kodama Y; Sakurai T; Mizugishi K; Uchida K; Kadowaki N; Takaori-Kondo A; Kudo M; Okazaki K; Strober W; Chiba T; Watanabe T
J Immunol; 2015 Oct; 195(7):3033-44. PubMed ID: 26297761
[TBL] [Abstract][Full Text] [Related]
12. Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease.
Okazaki K; Ikeura T; Uchida K
Mod Rheumatol; 2023 Mar; 33(2):237-241. PubMed ID: 35737955
[TBL] [Abstract][Full Text] [Related]
13. Cytokines produced by innate immune cells in IgG4-related disease.
Yoshikawa T; Watanabe T; Minaga K; Kamata K; Kudo M
Mod Rheumatol; 2019 Mar; 29(2):219-225. PubMed ID: 30334477
[TBL] [Abstract][Full Text] [Related]
14. Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis.
Okamoto A; Watanabe T; Kamata K; Minaga K; Kudo M
Intern Med; 2019 Jun; 58(11):1533-1539. PubMed ID: 30713326
[TBL] [Abstract][Full Text] [Related]
15. Significant CA 19-9 elevation in IgG4-related autoimmune pancreatitis - A diagnostic dilemma.
Farrukh L; Akhtar MF; Waqar HH; Peredo-Wende R
Am J Med Sci; 2024 Jan; 367(1):67-71. PubMed ID: 37714269
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment.
Okazaki K
Dig Dis Sci; 2019 Sep; 64(9):2385-2394. PubMed ID: 31363956
[TBL] [Abstract][Full Text] [Related]
17. Is autoimmune pancreatitis a risk factor for pancreatic adenocarcinoma?
Kunovský L; Dítě P; Blaho M; Dvořáčková J; Uvírová M; Přecechtělová M; Jabandžiev P; Mašková H; Kianička B; Janeček P; Eid M; Martínek A
Vnitr Lek; 2021; 67(1):9-13. PubMed ID: 33752395
[TBL] [Abstract][Full Text] [Related]
18. The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis.
de Pretis N; Amodio A; De Marchi G; Marconato E; Ciccocioppo R; Frulloni L
Expert Rev Clin Immunol; 2022 Nov; 18(11):1119-1124. PubMed ID: 36125384
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in IgG4-related autoimmune pancreatitis.
Yang X; Zhou H; Wang W; Yan C; Ji G
Pathol Res Pract; 2024 May; 257():155331. PubMed ID: 38678849
[TBL] [Abstract][Full Text] [Related]
20. A unique profile of serum cytokines in type 1 autoimmune pancreatitis and chronic rhinosinusitis.
Yoshikawa T; Minaga K; Hara A; Sekai I; Otsuka Y; Takada R; Kamata K; Watanabe T; Kudo M
Asian Pac J Allergy Immunol; 2021 Feb; ():. PubMed ID: 33638626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
